KRAS mutation status is not predictive for objective response to anti-EGFR treatment with erlotinib in patients with advanced pancreatic cancer

✍ Scribed by Stefan Boeck, Andreas Jung, Rüdiger P. Laubender…

• Book ID: 120914532
• Publisher: Springer Japan
• Year: 2013
• Tongue: English
• Weight: 195 KB
• Volume: 48
• Category: Article
• ISSN: 0944-1174
• DOI: 10.1007/s00535-013-0767-4